PART
II
|
|
|
|
Item 5.
|
Market
for Registrants Common Equity and Related Stockholder
Matters and Issuer Purchases of Equity Securities
|
Our common stock has been traded on The Nasdaq National Market
under the symbol AVNC since October 17, 2003. The following
table sets forth the quarterly high and low sales prices per
share of our common stock as reported by Nasdaq for each quarter
during the last two fiscal years, commencing on January 1,
2004:
|
|
|
|
|
|
|
|
|
|
|
|
|
HIGH
|
|
|
LOW
|
|
|
|
|
December 31, 2005:
|
|
|
|
|
|
|
|
|
|
Fourth quarter
|
|
$
|
1.69
|
|
|
$
|
1.20
|
|
|
Third quarter
|
|
|
2.75
|
|
|
|
0.86
|
|
|
Second quarter
|
|
|
5.40
|
|
|
|
1.70
|
|
|
First quarter
|
|
|
5.42
|
|
|
|
3.03
|
|
|
December 31, 2004:
|
|
|
|
|
|
|
|
|
|
Fourth quarter
|
|
$
|
8.60
|
|
|
$
|
2.50
|
|
|
Third quarter
|
|
|
9.05
|
|
|
|
6.73
|
|
|
Second quarter
|
|
|
9.74
|
|
|
|
6.58
|
|
|
First quarter
|
|
|
10.15
|
|
|
|
7.34
|
|
As of February 28, 2006, there were 132 holders of record
of our common stock. This figure does not represent the actual
number of beneficial owners of our common stock because shares
are generally held in street name by securities
dealers and others for the benefit of individual owners who may
vote the shares.
We have never declared or paid any cash dividends on our common
stock. We currently intend to retain our future earnings, if
any, to finance the further development and expansion of our
business and do not intend to pay cash dividends for the
foreseeable future. Any future determination to pay dividends
will be at the discretion of our board of directors and will
depend on our financial condition, results of operations,
capital requirements, restrictions contained in current or
future financing instruments and such other factors as our board
of directors deems relevant.
From October 15, 2003, the effective date of our
Registration Statement on
Form S-1
(File
No. 333-107599),
to December 31, 2005, we have used the entire
$54.3 million of the net offering proceeds from our initial
public offering, as follows:
|
|
|
|
|
|
|
Purchase of Keflex intangible
assets
|
|
$
|
11,206,000
|
|
|
Purchases of property and equipment
|
|
|
4,768,000
|
|
|
Cash used for debt payments
|
|
|
1,513,000
|
|
|
Cash used in operating activities
|
|
|
36,825,000
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
54,312,000
|
|
|
|
|
|
|
|
30